Title: Longitudinal Continuous Glucose Monitoring Study in Young Children With Presymptomatic Type 1 Diabetes Followed in the Environmental Determinants of Islet Autoimmunity (ENDIA) At-Risk Cohort Study
Authors: Haynes, A
Smith, GJ
Tully, A
Mellor, BR
Penno, MAS
Craig, ME
Wentworth, JM
Huynh, T
Colman, PG
Soldatos, G
Anderson, AJ
McGorm, KJ
Couper, JJ
Davis, EA
Barry, SC
Hamilton-Williams, EE
Harrison, LC
Kim, KW
Morahan, G
Oakey, H
Rawlinson, WD
Thomson, RL
Tye-Din, J
Vuillermin, PJ
Issue Year: 2025
Publisher AMER DIABETES ASSOC
Series DIABETES CARE:
Abstract OBJECTIVE To characterize longitudinal continuous glucose monitoring (CGM) data in young children with presymptomatic type 1 diabetes. RESEARCH DESIGN AND METHODS Between 2021 and 2024, children in the Australian ENDIA study with persistent multiple islet autoimmunity underwent blinded CGM assessments every 3-6 months. CGM-derived metrics (SD sensor glucose, coefficient of variation, mean sensor glucose, and percent CGM time >7.8 mmol/L [140 mg/dL]) were determined for each child by time from islet autoantibody detection. RESULTS A total of 178 CGM assessments were analyzed for 36 children (median [Q1, Q3] age at first assessment 4.5 [3.5, 6.0] years) who underwent a median of 5.5 (2.0, 7.0) assessments of 11 (9, 15) days duration each. High within-person variability was observed in serial CGM metrics, including percent CGM time >7.8 mmol/L (140 mg/dL) (intraclass correlation coefficient 0.30). CONCLUSIONS Further research is needed to inform interpretation of CGM-derived metrics in young children with presymptomatic type 1 diabetes.
URI: https://publications.svi.edu.au/publications/10194
Other Identifiers 10.2337/dc25-0821
Publication type Article